610 filings
Page 4 of 31
4
BLPH
Bellerophon Therapeutics, Inc.
22 May 23
Bellerophon Therapeutics / Bobae Kim ownership change
6:51pm
SC 13D/A
Puissance Life Science Opportunities Fund VI
22 May 23
Bellerophon Therapeutics / Puissance Life Science Opportunities Fund VI ownership change
7:04am
4
Puissance Capital Fund
19 May 23
Bellerophon Therapeutics / Theodore T Wang ownership change
8:55pm
144
BLPH
Bellerophon Therapeutics, Inc.
18 May 23
Notice of proposed sale of securities
8:50pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
15 May 23
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
4:54pm
10-Q
2023 Q1
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
15 May 23
4:30pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
11 May 23
Departure of Directors or Certain Officers
5:06pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
11 May 23
Pivotal top-line data readout expected in mid-2023
8:30am
8-K
BLPH
Bellerophon Therapeutics, Inc.
5 May 23
Departure of Directors or Certain Officers
4:59pm
ARS
2022 FY
BLPH
Bellerophon Therapeutics, Inc.
28 Apr 23
Annual report to shareholders
8:38am
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
28 Apr 23
Additional proxy soliciting materials
8:34am
DEF 14A
BLPH
Bellerophon Therapeutics, Inc.
Definitive proxy
28 Apr 23
8:32am
8-K
BLPH
Bellerophon Therapeutics, Inc.
25 Apr 23
Departure of Directors or Certain Officers
5:00pm
3
Bobae Kim
3 Apr 23
Bellerophon Therapeutics / Bobae Kim ownership change
5:46pm
10-K
2022 FY
BLPH
Bellerophon Therapeutics, Inc.
Annual report
31 Mar 23
8:30am
8-K
BLPH
Bellerophon Therapeutics, Inc.
31 Mar 23
Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
8:29am
SC 13G
BLPH
Bellerophon Therapeutics, Inc.
17 Mar 23
Bellerophon Therapeutics / TANG CAPITAL PARTNERS ownership change
4:00pm
SC 13G
BLPH
Bellerophon Therapeutics, Inc.
14 Mar 23
Bellerophon Therapeutics / PERCEPTIVE ADVISORS ownership change
10:55am
424B5
BLPH
Bellerophon Therapeutics, Inc.
6 Mar 23
Prospectus supplement for primary offering
4:25pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
6 Mar 23
Entry into a Material Definitive Agreement
8:30am